Product logins

Find logins to all Clarivate products below.


Dr Dilpreet Singh, MD Ortho

Partner & Head JAPAC Consulting, Clarivate Consulting Services

Dr. Dilpreet Singh, is an experienced life sciences consultant with over 20 years in pharma & biotech. A surgeon turned management consultant turned entrepreneur and back to consulting, he has breadth of experience across the pharma & life sciences segments including operations & strategy execution.

Dilpreet was a Sr. Principal at L.E.K. Consulting and IQVIA (earlier IMS Health), leading the consulting practice across the SEA and APAC region. He has been a trusted advisor to clients across Market access & Go-to-market strategies, product and portfolio lifecycle management from R&D investments to licensing or launch, along with corporate strategies such as M&A, divestment and partnerships. He also has industry experience, most recently at Cerecin, being the COO of the neuro focused biotech with P3 asset in Alzheimer’s Disease and also at Johnson & Johnson earlier.

He has also been a speaker at industry leading events (eg APACMed, ESMO Asia etc), with published thought leadership across new and emerging technologies, and commercial models in biopharma and medical devices space

Dilpreet is passionate about technology in life sciences and founded Juvoxa, a health-tech patient-centric care platform to drive evidence driven outcomes in specialty care. He is actively involved in startup ecosystem in the region, and is an active investor, mentor and advisor to some promising early-stage startups in the region as well.

Dilpreet holds an MBA from the Indian School of Business, Hyderabad and Masters in Surgery (Orthopedics) from All India Institute of Medical Sciences, Delhi

Latest news

News March 30, 2026
Clarivate Selected by University of Texas at Dallas Libraries to Provide Alma Specto

Alma Specto, an AI-native digital collection and exhibition platform offers UT Dallas Libraries a scalable, flexible and future-ready solution, expanding the reach of its Special Collections to new audiences London,…

News March 26, 2026
Clarivate Reveals the AI50 – the Organizations Leading Artificial Intelligence Invention

London, U.K. March, 26, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Clarivate AI50, a new data-driven benchmark of organizations demonstrating exceptional leadership in…

News March 25, 2026
Annual Report to Identify 189 Global Engineering Fronts Released by Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China

A comprehensive outlook on engineering innovations London, U.K. March 25, 2026. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, the Chinese Academy of Engineering (CAE) and the…

Related resources

How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center